CAS: 43054-45-1; Clomiphene Citrate

结构式图片

MSDS等安全信息

    合成工艺路线路线简述

      海关参考信息

      专利信息


      专利号:US-2025289827-A1
      优先权日:2022-12-02
      标 题:Morphic forms of a mutant braf degrader and methods of manufacture thereof
      发明人:YU ROBERT T; HE MINSHENG; SCHNADERBECK MATTHEW J; KREGER BRIDGET; POLLOCK ROY MACFARLANE; JIANG SIYI; LI MEIQI; CHEN BOLU; LU JIANNAN
      权利人:C4 THERAPEUTICS INC
      摘要:Advantageous isolated morphic forms of (3R)-3-[6-[2-cyano-3-[[ethyl(methyl)sulfamoyl]amino]-6-fluorophenoxy]-4-oxoquinazolin-3-yl]-8-[2-[1-[3-(2,4-dioxo-1,3-diazinan-1-yl)-5-fluoro-1-methylindazol-6-yl]-4-hydroxypiperidin-4-yl]acetyl]-1-oxa-8-azaspiro[4.5]decane (Compound 1), which is a mutant BRAF degrader, and methods to prepare Compound 1 morphic forms for therapeutic applications are provided in the invention. The invention also provides improved methods for the synthesis of Compound 1, new pharmaceutical compositions comprising Compound 1, and new uses of Compound 1.

      专利号:US-9180171-B2
      优先权日:2011-01-25
      标题 :Method of regulating fertilizing ability using cyclic ADP-ribose and CD38
      发明人:KIM UH-HYUN; PARK KWANG-HYUN; KIM BYUNG-JU
      权利人:NAT UNIV CHONBUK IND COOP FOUND
      摘要:The present invention relates to a pharmaceutical composition for promoting fertilization comprising cyclic ADP-ribose or its derivative, CD38 and to a method of promoting fertilization by promoting the synthesis of cyclic ADP-ribose to increase sperm motility. Also, the present invention relates to a pharmaceutical composition for contraception and a method for inhibiting fertilization, which can inhibit the expression or function of cyclic ADP-ribose to reduce sperm motility, thereby inhibiting fertilization.

      专利号:US-9914696-B2
      优先权日:2014-03-11
      标 题:Clomiphene synthesis using a single solvent
      发明人:PODOLSKI JOSEPH S; HSU KUANG
      权利人:REPROS THERAPEUTICS INC
      摘要:The present invention provides a one-pot method for synthesizing clomiphene (a mixture of the isomers cis-clomiphene and trans-clomiphene) utilizing a single solvent. In a preferred embodiment, the single solvent is dichloromethane (DCM, also known as methylene chloride). The present invention provides an improved method for synthesizing clomiphene and purifying clomiphene isomers.

      专利号:US-2005053642-A1
      优先权日:2000-08-23
      标题:Biocompatible materials
      发明人:ULBRICHT MATHIAS; THOM VOLKMAR; JANKOVA KATJA; ALTANKOV GEORGE; JONSSON GUNNAR
      摘要:The present invention teaches a novel approach of creating biocmpatible surfaces, said surfaces being capable of functionally interact with biological material. SAid biocompatible surfaces comrise at least two comonents, such as a hydrophobic substratum and a macromolecule of hydrophilic nature, which, in a cooperativity, form together the novel biocoompatible surfaces. The novel approach is ased on contacting said hydrophobic substratum with a laterally patterned monomolecular layer of said hydrophilic and flexible macromolecules, exhibiting a pronounced excluded volume. The htus formed two component surface is, in respect to polarity and morphology, a molecularly heterogeneous surface. Structural features of said macromolecular monolayer (as e.g. the layer thickness or its lateral density) are determined by: i) the structural features of the layer forming macromolecules (as e.g. their MW or their molecular architecture) and ii) the method of creating said monomolecular layer (as e.g. by physi- or chemisorbing, or by chemically binding said macromolecules). The structural features of the layer forming macromolecules(s) is in turn determined by synthesis. AMount and conformation and thus also biological activity of biological material (as e.g. polypeptides) which contact the novel biocompatible surface, is determined and maintained by the cooperative action of the underlying hydrophobic substratum and the macromolecular layer. In this way it becomes possible to maintain and control biological interactions between said contacted polypeptides and other biological compounds as e.g. cells, antibodies and the like. Consequently, the present invention aims to reduce and/or eliminate the deactivation and/or denaturation associated with the contacting of polypeptides and/or other biological material to a hydrophobic substratum surface.

      专利号:US-6403576-B1
      优先权日:1998-08-24
      标题 :Antifungal and antiparasitic compounds
      发明人:JACKSON JOAN E; IWU MAURICE M; OKUNJI CHRISTOPHER O; BACCHI CYRUS; TALLY JR JOHN D; AYAFOR JOHNSON F
      权利人:US ARMY
      摘要:Novel antiparasitic and antifungal compositions are disclosed. The antiparasitic and antifungal compositions are useful for human and veterinary therapy for the treatment and/or prevention of parasitic infection. Also disclosed are novel mechanisms of identifying antifungal and antiparasitic compositions by their biochemical action on lipid synthesis and/or metabolism and/or excretion.

      供应商参考报价(招募中)

      品牌试剂参考报价(招募中)

      📌 第三方产品分析报告

      ✅ COA系统入驻 | 共享模式

      合成参考文献


      参考文献:10.1007/s00404-011-1983-x
      摘要:Abu Hashim H, Foda O, Ghayaty E, Elawa A. RETRACTED ARTICLE: Laparoscopic ovarian diathermy after clomiphene failure in polycystic ovary syndrome: is it worthwhile A randomized controlled trial. Arch Gynecol Obstet. 2011 Jul 14;284(5):1303–9. doi: 10.1007/s00404-011-1983-x.
      参考文献:10.1007/s00404-011-1997-4
      摘要:Berker B, Kahraman K, Taskin S, Sukur YE, Sonmezer M, Atabekoglu CS. Recombinant FSH versus clomiphene citrate for ovarian stimulation in couples with unexplained infertility and male subfertility undergoing intrauterine insemination: a randomized trial. Archives of Gynecology and Obstetrics. 2011 Jul 20;284(6):1561–6. doi: 10.1007/s00404-011-1997-4.
      参考文献:10.1007/s00404-011-2007-6
      摘要:Mekaru K, Yagi C, Asato K, Masamoto H, Sakumoto K, Aoki Y. Hysteroscopic tubal catheterization under laparoscopy for proximal tubal obstruction. Archives of Gynecology and Obstetrics. 2011 Jul 21;284(6):1573–6. doi: 10.1007/s00404-011-2007-6.
      参考文献:10.1007/s10815-011-9612-y
      摘要:Ben-Meir A, Shveiky D, Zivi E, Feigenberg T, Revel A, Simon A, Laufer N. The value of human chorionic gonadotropin stimulation test in predicting ovarian response during in-vitro fertilization. Journal of Assisted Reproduction and Genetics. 2011 Jul 21;28(10):893–9. doi: 10.1007/s10815-011-9612-y.
      📝 需求与反馈
      尽可能描述清楚需求与问题信息
      ×

      通知